WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported first-quarter profit of $8.1 million.
The Waltham, Massachusetts-based company said it had net income of 17 cents per share. Earnings, adjusted for one-time gains and costs, came to 28 cents per share.
The drug developer posted revenue of $60.6 million in the period.
Repligen expects full-year earnings in the range of 84 cents to 90 cents per share.
Repligen shares have risen 28% since the beginning of the year. The stock has climbed 67% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGEN at https://www.zacks.com/ap/RGEN